Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC for severe COVID-19 pneumonia
ChiCTR2000030138Phase 2Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2020
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of human umbilical cord mesenchymal stem cells in coronavirus disease 2019 (COVID-19) and viral pneumonia (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Clinical index. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)viral pneumonia
Beyond the preview
Go deeper on ChiCTR2000030138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000030138.